These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26997002)

  • 21. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
    Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenodiagnosis on dogs with visceral leishmaniasis: Canine and sand fly aspects related to the parasite transmission.
    Magalhães-Junior JT; Mota TF; Porfirio-Passos G; Larangeira DF; Franke CR; Barrouin-Melo SM
    Vet Parasitol; 2016 Jun; 223():120-6. PubMed ID: 27198788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental Factors and Ecosystems Associated with Canine Visceral Leishmaniasis in Northeastern Brazil.
    da Costa AP; Costa FB; Soares HS; Ramirez DG; de Carvalho Araújo A; da Silva Ferreira JI; Tonhosolo R; Dias RA; Gennari SM; Marcili A
    Vector Borne Zoonotic Dis; 2015 Dec; 15(12):765-74. PubMed ID: 26684524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of the DPP(®) CVL rapid test for canine serodiagnosis in area of visceral leishmaniasis.
    Laurenti MD; de Santana Leandro MV; Tomokane TY; De Lucca HR; Aschar M; Souza CS; Silva RM; Marcondes M; da Matta VL
    Vet Parasitol; 2014 Oct; 205(3-4):444-50. PubMed ID: 25257505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend® against canine leishmaniosis.
    Fernández Cotrina J; Iniesta V; Monroy I; Baz V; Hugnet C; Marañon F; Fabra M; Gómez-Nieto LC; Alonso C
    Vaccine; 2018 Apr; 36(15):1972-1982. PubMed ID: 29525281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of two recombinant Leishmania proteins identified by an immunoproteomic approach as tools for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
    Coelho EA; Costa LE; Lage DP; Martins VT; Garde E; de Jesus Pereira NC; Lopes EG; Borges LF; Duarte MC; Menezes-Souza D; de Magalhães-Soares DF; Chávez-Fumagalli MA; Soto M; Tavares CA
    Vet Parasitol; 2016 Jan; 215():63-71. PubMed ID: 26790739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals.
    Gradoni L; Foglia Manzillo V; Pagano A; Piantedosi D; De Luna R; Gramiccia M; Scalone A; Di Muccio T; Oliva G
    Vaccine; 2005 Nov; 23(45):5245-51. PubMed ID: 16054272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection of human and canine visceral leishmaniasis: assessment of a latex agglutination test based on the A2 antigen from amastigote forms of Leishmania infantum.
    Akhoundi B; Mohebali M; Shojaee S; Jalali M; Kazemi B; Bandehpour M; Keshavarz H; Edrissian GH; Eslami MB; Malekafzali H; Kouchaki A
    Exp Parasitol; 2013 Mar; 133(3):307-13. PubMed ID: 23276878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.
    Nogueira FS; Moreira MA; Borja-Cabrera GP; Santos FN; Menz I; Parra LE; Xu Z; Chu HJ; Palatnik-de-Sousa CB; Luvizotto MC
    Vaccine; 2005 Sep; 23(40):4805-10. PubMed ID: 16011864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of enzyme-linked immunosorbent assay using crude Leishmania and recombinant antigens as a diagnostic marker for canine visceral leishmaniasis.
    Rosário EY; Genaro O; Franca-Silva JC; da Costa RT; Mayrink W; Reis AB; Carneiro M
    Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):197-203. PubMed ID: 16021309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dispersal of Lutzomyia longipalpis and expansion of canine and human visceral leishmaniasis in São Paulo State, Brazil.
    Oliveira AM; Vieira CP; Dibo MR; Guirado MM; Rodas LAC; Chiaravalloti-Neto F
    Acta Trop; 2016 Dec; 164():233-242. PubMed ID: 27640322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil.
    Nunes CM; Lima VM; Paula HB; Perri SH; Andrade AM; Dias FE; Burattini MN
    Vet Parasitol; 2008 May; 153(1-2):19-23. PubMed ID: 18314275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.
    Miret J; Nascimento E; Sampaio W; França JC; Fujiwara RT; Vale A; Dias ES; Vieira E; da Costa RT; Mayrink W; Campos Neto A; Reed S
    Vaccine; 2008 Mar; 26(12):1585-94. PubMed ID: 18328956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
    de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scoring clinical signs can help diagnose canine visceral leishmaniasis in a highly endemic area in Brazil.
    Silva KR; Mendonça VR; Silva KM; Nascimento LF; Mendes-Sousa AF; Pinho FA; Barral-Netto M; Barral AM; Cruz MD
    Mem Inst Oswaldo Cruz; 2017 Jan; 112(1):53-63. PubMed ID: 28076469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.
    Martins VT; Chávez-Fumagalli MA; Costa LE; Canavaci AM; Martins AM; Lage PS; Lage DP; Duarte MC; Valadares DG; Magalhães RD; Ribeiro TG; Nagem RA; Darocha WD; Régis WC; Soto M; Coelho EA; Fernandes AP; Tavares CA
    PLoS Negl Trop Dis; 2013; 7(3):e2148. PubMed ID: 23573301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a prototype flow cytometry test for serodiagnosis of canine visceral leishmaniasis.
    Ker HG; Coura-Vital W; Aguiar-Soares RD; Roatt BM; das Dores Moreira N; Carneiro CM; Machado EM; Teixeira-Carvalho A; Martins-Filho OA; Giunchetti RC; Araújo MS; Coelho EA; da Silveira-Lemos D; Reis AB
    Clin Vaccine Immunol; 2013 Dec; 20(12):1792-8. PubMed ID: 24108778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of a real time PCR for leishmaniasis diagnosis using a L. (L.) infantum hypothetical protein as target in canine samples.
    Colombo FA; Pereira-Chioccola VL; Meira Cda S; Motoie G; Gava R; Hiramoto RM; de Almeida ME; da Silva AJ; Cutolo AA; Menz I
    Exp Parasitol; 2015 Oct; 157():156-62. PubMed ID: 26297683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.